Depressive Disorder Comorbid With Cancer clinical trials

Explore recruiting depressive disorder comorbid with cancer clinical trials.

Also recruiting in Europe

Depressive Disorder Comorbid With Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possibility of entering open extension

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Depressive Disorder Comorbid With Cancer trials by city

Depressive Disorder Comorbid With Cancer in Toronto Depressive Disorder Comorbid With Cancer in Vancouver Depressive Disorder Comorbid With Cancer in Montreal Depressive Disorder Comorbid With Cancer in Calgary Depressive Disorder Comorbid With Cancer in Edmonton Depressive Disorder Comorbid With Cancer in Ottawa Depressive Disorder Comorbid With Cancer in Winnipeg Depressive Disorder Comorbid With Cancer in Quebec City Depressive Disorder Comorbid With Cancer in Hamilton Depressive Disorder Comorbid With Cancer in Kitchener Depressive Disorder Comorbid With Cancer in London Depressive Disorder Comorbid With Cancer in Halifax Depressive Disorder Comorbid With Cancer in New York Depressive Disorder Comorbid With Cancer in Los Angeles Depressive Disorder Comorbid With Cancer in Chicago Depressive Disorder Comorbid With Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease